Literature DB >> 9138078

Basic FGF regulates interstitial collagenase gene expression in human smooth muscle cells.

S H Kennedy1, S Rouda, H Qin, S Aho, J Selber, E M Tan.   

Abstract

Basic fibroblast growth factor (bFGF) is a mitogenic factor that is implicated in smooth muscle cell growth in atherosclerosis and vascular restenosis. In this study, we examined the effect of bFGF on the expression of the interstitial collagenase gene in human vascular smooth muscle cells. Results from Northern transfer analysis showed that bFGF increased collagenase mRNA levels greater than threefold as early as 24 h. Collagenase pre-mRNA levels were elevated approximately threefold by bFGF, according to RT-PCR analysis. Transient transfections of the smooth muscle cells with a 4.4-kb human collagenase promoter-CAT reporter gene, however, failed to show upregulation of the promoter activity by bFGF. Interestingly, transfections with deleted fragments containing promoter sequences from -1047 to -2271 resulted in modest stimulation of the collagenase-CAT promoter activity by bFGF, bFGF did not alter the stability of the collagenase mRNA, as demonstrated by degradation studies. The enhanced collagenase mRNA levels elicited by bFGF were reflected in increased amounts of collagenase protein that were detected by Western blot analysis. In summary, bFGF upregulates the interstitial collagenase expression, resulting in turnover of the extracellular matrix, an event that could facilitate smooth muscle cell migration and proliferation during the early stages of atherosclerosis and restenosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9138078

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  6 in total

1.  Production of basic fibroblast growth factor and interleukin 6 by human smooth muscle cells following infection with Chlamydia pneumoniae.

Authors:  J Rödel; M Woytas; A Groh; K H Schmidt; M Hartmann; M Lehmann; E Straube
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

2.  Supra-additive expression of interleukin-6, interleukin-8 and basic fibroblast growth factor in vascular smooth muscle cells following coinfection with Chlamydia pneumoniae and cytomegalovirus as a novel link between infection and atherosclerosis.

Authors:  Dirk Prochnau; Eberhard Straube; Hans-Reiner Figulla; Jürgen Rödel
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

Review 3.  Fibroblast Growth Factor 2 as an Antifibrotic: Antagonism of Myofibroblast Differentiation and Suppression of Pro-Fibrotic Gene Expression.

Authors:  David M Dolivo; Sara A Larson; Tanja Dominko
Journal:  Cytokine Growth Factor Rev       Date:  2017-09-23       Impact factor: 7.638

4.  Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents.

Authors:  Mohamed Izikki; Christophe Guignabert; Elie Fadel; Marc Humbert; Ly Tu; Patricia Zadigue; Philippe Dartevelle; Gerald Simonneau; Serge Adnot; Bernard Maitre; Bernadette Raffestin; Saadia Eddahibi
Journal:  J Clin Invest       Date:  2009-02-09       Impact factor: 14.808

5.  Pharmacological effects of Radix Angelica Sinensis (Danggui) on cerebral infarction.

Authors:  Yi-Chian Wu; Ching-Liang Hsieh
Journal:  Chin Med       Date:  2011-08-25       Impact factor: 5.455

6.  A Novel Xenograft Model Demonstrates Human Fibroblast Behavior During Skin Wound Repair and Fibrosis.

Authors:  Mimi R Borrelli; Abra H Shen; Michelle Griffin; Shamik Mascharak; Sandeep Adem; Nestor M Diaz Deleon; Ledibabari Mildred Ngaage; Michael T Longaker; Derrick C Wan; Hermann Peter Lorenz
Journal:  Adv Wound Care (New Rochelle)       Date:  2021-10-26       Impact factor: 4.947

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.